RYAN PRINCE: Open Payments
NPI 1124374434 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 7 payments from 6 companies in 2025. Trend: 2023 $391 · 2024 $162 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $148 |
| Amgen Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $109 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| PFIZER INC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: IMDELLTRA (AMG757), RYBREVANT, KEYTRUDA, DARZALEX, ELIQUIS, LYNPARZA.
Industry payments across FL — which companies pay providers there.
